RETATRUTIDE: 10 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
Route: TOPICAL · Manufacturer: Guangzhou Yixin Cross-border E-commerce Co., Ltd. · HUMAN OTC DRUG · FDA Label: Available
First Report: 20241109 · Latest Report: 20250909
What Are the Most Common RETATRUTIDE Side Effects?
All RETATRUTIDE Side Effects by Frequency
Who Reports RETATRUTIDE Side Effects? Age & Gender Data
Gender: 100.0% female, 0.0% male. Average age: 49.7 years. Most reports from: US. View detailed demographics →
Is RETATRUTIDE Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2024 | 1 | 0 | 0 |
| 2025 | 8 | 0 | 3 |
Official FDA Label for RETATRUTIDE
Official prescribing information from the FDA-approved drug label.
FDA Approved Uses (Indications)
Uses To support weight management To improve glycemic control in adults with type 2 diabetes mellitus Provides long-acting sustained-release delivery via soluble microneedle patch
Dosage & Administration
Dosage and administration
- Apply one transdermal patch containing 20 mg Retatrutide to the wrist or the back of the hand.
- Leave the patch in place for 30 to 60 minutes, then remove.
- Administer once every 3 to 7 days.
- Do not reuse a patch.
- Use only as directed.
Warnings
Warnings For external use only
Inactive Ingredients
Inactive ingredients Microcrystalline matrix, soluble microneedle polymer blend, stabilizers, adhesive layer.